A Look At China Life Insurance (SEHK:2628) Valuation As Board Prepares 2025 Results And Dividend Decision

Board meeting puts dividend and 2025 results in focus

China Life Insurance (SEHK:2628) has set March 25, 2026 for a board meeting to approve its 2025 annual results and consider a final dividend, an event that may be important for shareholders tracking capital returns.

This meeting will provide fresh information on the insurer’s financial performance, how management is thinking about capital allocation, and what that could mean for future cash returns through dividends.

See our latest analysis for China Life Insurance.

At a share price of HK$28.8, China Life Insurance has seen a 14.54% 1 month share price decline and an 8.80% 7 day pullback. However, its 1 year total shareholder return of 87.77% and 3 year total shareholder return of 154.06% still point to earlier strong momentum that now appears to be cooling ahead of the results and dividend decision.

If this dividend update has you thinking more broadly about income and quality, it could be a good moment to scan our 100 top founder-led companies as potential new ideas for your watchlist.

With the share price under pressure, yet trading at a discount to analysts’ targets and some models of intrinsic value, is China Life Insurance being overlooked here, or is the market already pricing in the growth that investors are hoping for?

Most Popular Narrative: 12.6% Undervalued

Compared with the last close at HK$28.8, the most followed narrative points to a fair value of about HK$32.96, putting fresh focus on what is baked into those assumptions ahead of the 2025 results and dividend decision.

The analysts have a consensus price target of HK$23.551 for China Life Insurance based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of HK$31.01, and the most bearish reporting a price target of just HK$14.24.

Read the complete narrative.

Want to know what justifies a higher fair value than the consensus target implies? Revenue expansion, margin resets and a richer future earnings multiple sit at the core of this narrative. Curious how those moving parts combine into a single HK$ figure and what kind of growth profile that assumes? The full story joins these pieces together in a way the headline numbers alone do not show.

Result: Fair Value of HK$32.96 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this hinges on assumptions that could be tested if investment income proves volatile or if efforts to control comprehensive liability costs put pressure on profitability.

Find out about the key risks to this China Life Insurance narrative.

Next Steps

Given the mix of optimism and caution in this story, it helps to look at the same facts yourself and move quickly to form your own view. You can start with 4 key rewards and 2 important warning signs.

Looking for more investment ideas?

If you stop at just one company, you risk missing opportunities that better match your goals, so keep your watchlist evolving with fresh, well filtered ideas.

• Target strong fundamentals and resilient finances by scanning our solid balance sheet and fundamentals stocks screener (373 results) for companies that may better fit your comfort with risk.
• Hunt for potential value by reviewing our 222 high quality undervalued stocks, where you can spot shares that screen well on both quality and pricing metrics.
• Prioritise lower volatility by checking our 299 resilient stocks with low risk scores and see which names currently stand out on a risk focused profile.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com